About Peggy Van De Plassche

I’m here to flip stereotypes on their head. Based on the stigmas that exist, I might be the last person you would expect to use magic mushrooms. A former banker and venture capitalist, I have allocated several billion dollars to tech investments, led innovation for a large multinational corporation, and launched several companies.

As you might imagine, I’m very type-A and have always been focused on doing “the right thing.” Health is of paramount importance to me. I’m an avid tennis player, a gym rat, and am very cautious about putting as few chemicals as possible in my body.

But microdosing magic mushrooms - also known as psilocybin - has become a critical part of my wellness journey—and it has for many other high performers like me too.     

 REWIRE YOUR BRAIN. CALM YOUR BODY. MASTER YOUR EMOTIONS. raise your energy.
FIND PERSONAL AND PROFESSIONAL SUCCESS.

What has been called the Psychedelics Renaissance is turning into the Psychedelics Gentrification. Psychedelics are going mainstream. What was used in the past in large quantities for “trips” by hippies, are now used daily in microdoses by CEOs, VCs and Moms for performance, mental health, happiness and personal transformation.

World-class publications such as The Economist, The Wall Street Journal, Financial Times, and The Washington Post, have been covering widely the progress psychedelics have made in the last few years, answering to the growing interest from millions.

The legal establishment, never one to moves fast, has surprised players all around the world with weekly announcements of legalization, decriminalization, and reclassification of psychedelics.

Scientists have been engaged in an exponential number of clinical trials with organizations such as the U.S. and Canadian Department of Veterans Affairs now testing the use of psychedelics to support the mental health of their members.

In 2018, the U.S. Food and Drug Administration named psilocybin a “breakthrough therapy” in treatment for severe depression, a designation the agency applies to drugs that in early trials demonstrate substantial improvement over existing treatments.

The market for psychedelics is projected to grow from $2 billion in 2020 to $10.75 billion by 2027; accordingly savvy investors and businesspeople have been busy developing new companies and investment funds to capture the profits.

 What MY audience SayS

“Thank you for helping me grow.”

“Several things long held dormant started to manifest in my life.”

“Thanks for the presentation this morning. It was very interesting. I would like to know which “product” you use and if you know practitioners in [a large US City] you might recommend. I want to look into this further.”

“Thanks for your bravery and vulnerability here. […] You've done a huge service to normalizing the responsible exploration of psilocybin and other alternative therapeutics.”

“Thank you so much. You did a great job. I was a bit nervous about what the group would think. They are a conservative group of men! But the man who was speaking the most is a doctor of neurosurgery and professor of rehabilitation medicine at [a large US] University! He came up to me afterward and told me how much he really enjoyed your presentation.”

“I wanted to reach out to thank you for sharing your insights and being vulnerable.”

“Peggy humble attitude, wealth of knowledge and courage is infectious.”

“Peggy is able to engage and inspire teams trough her vision, purpose and clearly leads by her example. She combines this with a wonderful humor, emotional intelligence and authenticity.”

empty

 empty